A prospective analysis of symptom burden for patients with chronic myeloid leukemia in chronic phase treated with frontline second‐ and third‐generation tyrosine kinase inhibitors.
Saved in:
| Title: | A prospective analysis of symptom burden for patients with chronic myeloid leukemia in chronic phase treated with frontline second‐ and third‐generation tyrosine kinase inhibitors. |
|---|---|
| Authors: | Zulbaran‐Rojas, Alejandro1, Lin, Huei‐Kan2, Shi, Qiuling2, Williams, Loretta A.2, George, Binsah1, Garcia‐Manero, Guillermo1, Jabbour, Elias1, O'Brien, Susan1, Ravandi, Farhad1, Wierda, William1, Estrov, Zeev1, Borthakur, Gautam1, Kadia, Tapan1, Cleeland, Charles2, Cortes, Jorge E.1 jcortes@mdanderson.org, Kantarjian, Hagop1 |
| Source: | Cancer Medicine. Nov2018, Vol. 7 Issue 11, p5457-5469. 13p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 20457634 |
|---|---|
| DOI: | 10.1002/cam4.1808 |
